Del Rosso James Q
Dr. Del Rosso is Research Director at JDR Dermatology Research in Las Vegas, Nevada; Adjunct Clinical Professor of Dermatology at Touro University Nevada, Las Vegas; and with Dermatology and Cutaneous Surgery at Thomas Dermatology in Las Vegas, Nevada.
J Clin Aesthet Dermatol. 2017 Sep;10(9):39-42. Epub 2017 Sep 1.
Until recently, the potential modes of action of topical ivermectin in rosacea have been speculated but not studied. Short-term studies (12 week), long-term studies (up to 52 weeks), and case report series have now been completed, and topical ivermectin (IVM), formulated as a 1% cream that is applied once daily, has been shown to be effective, well-tolerated, and safe for the treatment of rosacea. This article reviews outcomes from studies that support dual modes of action, including both anti-inflammatory and anti-parasitic effects.
直到最近,外用伊维菌素治疗酒渣鼻的潜在作用方式一直是推测性的,尚未得到研究。目前,短期研究(12周)、长期研究(长达52周)以及病例报告系列均已完成,外用伊维菌素(IVM)制成1%乳膏,每天涂抹一次,已被证明对治疗酒渣鼻有效、耐受性良好且安全。本文综述了支持双重作用方式的研究结果,包括抗炎和抗寄生虫作用。